Amgen AMGN spent $2.8M on lobbying in Q3 2024 · Health Issues, Medicare and 2 more issues

Trade details

Type: Lobbying report
Amount: $2,770,000
Quarter: Q3 2024
Stock: Amgen AMGN
Client: Amgen
Reported: 24/10/21

Up 1.1% from last quarter

What else happened in Amgen around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Amgen's other lobbying reports

Amgen
LobbyingAmgen
Lobbying
Amgen
AMGN
Under $5,000
Under $5,000
Reported 07/28
for Q2
Amgen
LobbyingAmgen
Lobbying
Amgen
AMGN
Under $5,000
Under $5,000
Reported 07/21
for Q2
Amgen
LobbyingAmgen
Lobbying
Amgen
AMGN
$50K
$50K
Reported 07/20
for Q2
Amgen
LobbyingAmgen
Lobbying
Amgen
AMGN
$80K
$80K
Reported 07/20
for Q2
Amgen
LobbyingAmgen
Lobbying
Amgen
AMGN
$60K
$60K
Reported 07/20
for Q2

Amgen AMGN spent $2.8M on lobbying in Q3 2024 · Health Issues, Medicare and 2 more issues | Whalegun